Exp Mol Med.
1999 Sep;31(3):126-133.
TGF-beta1 inhibition of apoptosis through the transcriptional up-regulation of
Bcl-X(L) in human monocytic leukemia U937 cells
- Affiliations
-
- 1Department of Pathology, College of Medicine, Kyung Hee University, Seoul,
Korea. Leejuhie@chollian.net
Abstract
-
To characterize the TGF-beta1 response of monocytic leukemia cells, we analyzed
the effects of TGF-beta1 on cell proliferation, differentiation, and apoptosis
of human monoblastic U937 cells. Treatment of cells with TGF-beta1 in the
absence of growth factors significantly enhanced cell viability. Flow cytometric
analysis of DNA content and CD14 expression revealed that TGF-beta1 does not
affect cell proliferation and differentiation. Consistent with these results was
the finding that no transcriptional induction of Cdk inhibitors such as p21Waf1,
p15Ink4b, and p27Kip1 was detected following TGF-beta1 treatment. Interestingly,
however, pretreatment of TGF-beta1 significantly inhibited Fas-, DNA damage-,
and growth factor deprivation-induced apoptosis. This antiapoptotic effect was
totally abrogated by anti-TGF-beta1 antibody. Quantitative RT-PCR analysis
demonstrated a dose- and time-dependent transcriptional up-regulation of
Bcl-X(L), suggesting its implication in the TGF-1-mediated antiapoptotic
pathway. We also observed elevated expression of c-Fos and PTEN/MMAC1. But, no
detectable change was recognized in expression of c-Jun, Fas, Fadd, Fap-1,
Bcl-2, and Bax. Taken together, our study shows that TGF-beta1 enhancement of
cellular viability is associated with its antiapoptotic effect, which may result
from the transcriptional up-regulation of Bcl-X(L).